U.S. jury rules for Amgen over cholesterol drug patents
 

U.S. jury rules for Amgen over cholesterol drug patents
March 16 (Reuters) - A federal jury has ruled in favor of Amgen Inc and against Sa**fi SA and Regeneron Pharmaceuticals Inc in a trial over the validity of patents for antibodies related to a cholesterol drug, Sa**fi and Regeneron said in a joint statement on Wednesday.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut..._g:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut..._g:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/UErpnMKNahk